Tag: Cancer: Prostate
Adding ADT to Radiotherapy Ups Mets-Free Survival in Prostate Cancer
In meta-analysis, adjuvant ADT prolongation also linked to improvement in metastasis-free survival, but not neoadjuvant ADT extension
Incidence of Advanced Lung Cancer Continues to Decline in the U.S.
During 2014 to 2018, incidence continued to increase slowly for female breast cancer, remained stable for prostate cancer
Response to Radiotherapy for Prostate Cancer Better in Black Men
Outcomes better for Black men compared with White men in clinical trials of definitive radiotherapy for localized prostate cancer
Prostate Cancer Screening Declined Following 2012 USPSTF Guidance
In addition, rates of metastatic disease increased across all races, but particularly among Black men
3D Imaging Technique Aids Diagnosis of Aggressive Prostate Cancer
Proof-of-concept study shows 3D method improves assessment of glandular features over traditional pathology
PSMA Nomogram May Predict Outcomes in Prostate Cancer
Nomogram estimate for individual's risk for nonlocalized disease on prostate-specific membrane antigen PET/CT linked to long-term outcomes
PSA Testing Rates Up in the U.S. After Change in Guidance
Prostate-specific antigen testing rates increased for men aged 40 to 89 years following 2017 revision of USPSTF recommendation on screening
Abiraterone Acetate + Prednisone Cuts Metastasis in Prostate Cancer
And standard of care plus abiraterone improves survival in men with metastatic castration-sensitive prostate cancer
Stockholm3 Test May Aid Risk Prediction in Prostate Cancer Screening
Stockholm3 of 0.11 or higher combined with MRI-targeted and systematic biopsies could detect significant cancers, reduce overdetection
Fear of Recurrence Persists for Some Prostate Cancer Survivors
Predictors include lower level of education, years since radical prostatectomy, FCR, no current adjuvant therapy, anxiety
